RedBox Rx Review
Appears to have shut downRedBox Rx is closed and is not taking new patients. It charged from $269 a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RedBox Rx is no longer taking new patients. This program appears to have shut down, so we're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
Last published price before it closed: $269/mo. No longer offered.
See our top-rated GLP-1 providers →RedBox Rx sold compounded semaglutide and tirzepatide by telehealth. It no longer does. In October 2026 every GLP-1 treatment page redirected to a page reading “This page is no longer available”, and weight loss was gone from the list of conditions it treats. Its other telehealth services still run.
Vetted alternatives to RedBox Rx
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
AgelessRx
Best for: microdosed compounded GLP-1s from a longevity clinic, or brand Wegovy at manufacturer pricing plus monitoring
Editorial score · methodology
RedBox Rx at a glance
- Status
- Closed: not taking new patients
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Last published price
- $269/mo (269/mo month-to-month, or 189/mo on a 6-month plan)
- What it included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How RedBox Rx scores
RedBox Rx has closed. These scores describe what it published when we last checked it, before it stopped taking patients.
Six columns, each one computed from something RedBox Rx published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.8/10$269/month is 35% above the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
2.5/10No price appears until the medical intake is finished. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on RedBox Rx
Last checked July 2026- Checked the listed price across 4 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for RedBox Rx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
Cancelling RedBox Rx
Taken from the terms RedBox Rx publishes. Terms change, so check the current policy before you subscribe.
- Minimum commitment
- None
- Refund policy
- Not published by the seller
Medications RedBox Rx listed
RedBox Rx listed compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Prices it published before closing
Prices re-verified
269/mo month-to-month, or 189/mo on a 6-month plan
daily oral dissolvable tablet
weekly injection, flat pricing
daily oral tablet
In its favor
- The monthly price stayed the same as the dose went up
- The monthly price included the medication, clinician visits and shipping
- We found no FDA warning letters issued to RedBox Rx
- A live video visit with a clinician was required before a prescription, which is slower than a form and is the more careful intake
Against it
- Semaglutide cost $269 a month, 35% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide cost $397 a month, 48% above the $269 median for compounded tirzepatide across the sellers we compare
- It showed a price only after the medical intake, so you could not compare costs before sharing health information
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
RedBox Rx is no longer taking new patients. What follows describes the program as it last ran, for anyone comparing it with a seller that is still open.
What RedBox Rx charged
$189 is a promotional price at RedBox Rx; the regular price is $269/month. Budget with the regular one unless the offer's terms say the lower price stays.
- Compounded semaglutide (injection): $189 promotional price, regular $269/month
- Compounded semaglutide (tablet): $279/month
- Compounded tirzepatide (injection): $429/month
- Compounded tirzepatide (tablet): $397/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so RedBox Rx's $269 is a premium, and a premium has to buy something. Plan the year on the regular price, not the promotional one.
Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.
What RedBox Rx dispensed
RedBox Rx prescribed semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at RedBox Rx at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
We found no FDA warning letters issued to RedBox Rx. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Our read
RedBox Rx is no longer taking new patients, so the choice is among the sellers that are still open.
The Bottom Line
RedBox Rx is closed and is not taking new patients. It charged from $269 a month.
Where RedBox Rx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to RedBox Rx sets more sellers in the same category beside RedBox Rx on price, states and what the price includes.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this RedBox Rx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.